If you enjoy this content, please share it with a colleague
RELATED CONTENT
December 19, 2017 — IBA (Ion Beam Applications SA) announced that Miami Cancer Institute treated its first patients ...
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful ...
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest ...
The new Visicoil MR is a helically-wound, flexible linear fiducial marker. The Visicoil MR hollow core design and ...
August 30, 2017 — IBA (Ion Beam Applications S.A.) and the Department of Radiation Oncology at Penn Medicine, in ...
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy solution, each treatment room equipped with pencil beam scanning capability and integrated cone beam computed tomography (CBCT). Inova plans to start treating patients by 2020 at the Inova Schar Cancer Institute on the Inova Center for Personalized Health campus in Annandale, Va.
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
IBA announced the accreditation of an International Competence Center (ICC) training course by the European Board for Accreditation in Medical Physics (EBAMP).
May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at the ...
IBA announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton therapy. ParTICLe, short for Particle Therapy Interuniversity Center Leuven, is a clinical and scientific collaboration between five university hospitals.